COL4A3 and Alport syndrome: This candidate was effective in reducing kidney fibrosis and improving kidney function to significantly extend the survival of Human Immunodeficiency Virus-Associated Nephropathy Transgenic 26 (HIVAN Tg26) and Collagen Type IV Alpha 3 Chain Null Alport Syndrome (Col4a3-null Alport syndrome) mice [9].